Skip to main content
Erschienen in: Strahlentherapie und Onkologie 3/2012

01.03.2012 | Original article

RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma

verfasst von: G.Z. Gong, Y. Yin, L.G. Xing, Y.J. Guo, T. Liu, J. Chen, J. Lu, C. Ma, T. Sun, T. Bai, G. Zhang, R. Wang

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The goal of this research was to investigate the feasibility of volumetric modulated arc therapy, RapidArc (RA), in association with the active breathing coordinator (ABC) for the treatment of hepatocellular carcinoma (HCC) with radiotherapy.

Patients and materials

A total of 12 patients with HCC, after receiving transcatheter arterial chemoembolization (TACE) treatment, underwent three-dimensional computer tomography (3D-CT) scanning associated with ABC using end inspiration hold (EIH), end expiration hold (EEH), and free breathing (FB) techniques. The three-dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT), and RA plans (three 135° arcs) were designed on different CT images, respectively. The liver volume, gross tumor volume (GTV), and planning target volume (PTV) of the three breath status and the dosimetric differences of the different plans were compared.

Results

There were no significant differences in the volumes of live and GTV between the three breathing techniques (p > 0.05); the PTV in FB was greater than in the EEH and EIH (p < 0.05). The overall conformality index (CI) and homogeneity index (HI) for RA (CI 0.92, HI 0.90) were better than IMRT (CI 0.90, HI 0.89) and 3D-CRT (CI 0.70, HI 0.84) for the three breathing techniques (p< 0.05). The RA and IMRT significantly reduced the mean dose, V20, V30, and V40 of normal liver compared to 3D-CRT, while the V5 and V10 in RA were higher than in IMRT. The mean values in mean dose, V10, V20, V30, and V40 of the normal liver were reduced from 13.12 Gy, 46%, 24%, 13%, and 8% in RAFB to 10.23 Gy, 35%, 16%, 8%, and 5% in RAEEH and 9.23 Gy, 32%, 16%, 8%, and 5% in RAEIH , respectively. In addition, the treatment time of RA was equal to 3D-CRT, which was significantly shorter than IMRT.

Conclusion

RA in conjunction with ABC for the treatment of HCC with radiotherapy can achieve better dose delivery and ensure the accuracy of the target volume, which spares more organs at risk, uses fewer monitor units, and shortens treatment time.
Literatur
1.
Zurück zum Zitat Wörns MA, Galle PR (2010) Future perspectives in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):302–309CrossRef Wörns MA, Galle PR (2010) Future perspectives in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):302–309CrossRef
2.
Zurück zum Zitat Whang-Peng J, Cheng AL, Hsu C et al (2010) Clinical development and future direction for the treatment of hepatocellular carcinoma. J Exp Clin Med 2(3):93–103CrossRef Whang-Peng J, Cheng AL, Hsu C et al (2010) Clinical development and future direction for the treatment of hepatocellular carcinoma. J Exp Clin Med 2(3):93–103CrossRef
3.
Zurück zum Zitat Seong J, Park HC, Han KH et al (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55(2):329–336PubMedCrossRef Seong J, Park HC, Han KH et al (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55(2):329–336PubMedCrossRef
4.
Zurück zum Zitat Merle P, Mornex F, Trepo C et al (2009) Innovative therapy for hepatocelluar carcinoma: three-dimensional high-dose photon radiotherapy. Cancer Lett 286:129–133PubMedCrossRef Merle P, Mornex F, Trepo C et al (2009) Innovative therapy for hepatocelluar carcinoma: three-dimensional high-dose photon radiotherapy. Cancer Lett 286:129–133PubMedCrossRef
5.
Zurück zum Zitat Tokuuye K, Sumi M, Kagami Y et al (2000) Radiotherapy for hepatocellular carcinoma. Strahlenther Onkol 176:406–410PubMedCrossRef Tokuuye K, Sumi M, Kagami Y et al (2000) Radiotherapy for hepatocellular carcinoma. Strahlenther Onkol 176:406–410PubMedCrossRef
6.
Zurück zum Zitat Hata M, Tokuuye K, Sugahara S, et al (2007) Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites: technical considerations and results. Strahlenther Onkol 183:411–416PubMedCrossRef Hata M, Tokuuye K, Sugahara S, et al (2007) Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites: technical considerations and results. Strahlenther Onkol 183:411–416PubMedCrossRef
7.
Zurück zum Zitat Sugahara S, Nakayama H, Fukuda K et al (2009) Proton-beam therapy for hepatocellular carcinoma associated with portal vein tTumor thrombosis. Strahlenther Onkol 185:782–788PubMedCrossRef Sugahara S, Nakayama H, Fukuda K et al (2009) Proton-beam therapy for hepatocellular carcinoma associated with portal vein tTumor thrombosis. Strahlenther Onkol 185:782–788PubMedCrossRef
8.
Zurück zum Zitat Gierga D, Chen G, Kung J et al (2004) Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int J Radiat Oncol Biol Phys; 58 (5):1584–1595 Gierga D, Chen G, Kung J et al (2004) Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int J Radiat Oncol Biol Phys; 58 (5):1584–1595
9.
Zurück zum Zitat Wang, JZ, Li XA, D’Souza WD et al (2003) Impact of prolonged fraction delivery times on tumor control probability: a note of caution for IMRT. Int J Radiat Oncol Biol Phys 57(2):543–552PubMedCrossRef Wang, JZ, Li XA, D’Souza WD et al (2003) Impact of prolonged fraction delivery times on tumor control probability: a note of caution for IMRT. Int J Radiat Oncol Biol Phys 57(2):543–552PubMedCrossRef
10.
Zurück zum Zitat Cozzi L, Dinshawc KA, Shrivastavac SK (2008) A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89:180–191PubMedCrossRef Cozzi L, Dinshawc KA, Shrivastavac SK (2008) A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89:180–191PubMedCrossRef
11.
Zurück zum Zitat Eppinga W, Lagerwaard F, Verbakel W et al (2010) Volumetric modulated arc therapy for advanced pancreatic cancer. Strahlenther Onkol 186:382–387PubMedCrossRef Eppinga W, Lagerwaard F, Verbakel W et al (2010) Volumetric modulated arc therapy for advanced pancreatic cancer. Strahlenther Onkol 186:382–387PubMedCrossRef
12.
Zurück zum Zitat Jacob V, Bayer W, Astner ST et al (2010) A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol 186:502–510PubMedCrossRef Jacob V, Bayer W, Astner ST et al (2010) A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol 186:502–510PubMedCrossRef
13.
Zurück zum Zitat Bignardi M, Cozzi L, Fogliata A et al (2009) Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes. Int J Radiat Oncol Biol Phys 75(5):1570–1577PubMedCrossRef Bignardi M, Cozzi L, Fogliata A et al (2009) Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes. Int J Radiat Oncol Biol Phys 75(5):1570–1577PubMedCrossRef
14.
Zurück zum Zitat Yin Y, Ma C, Gao M et al (2010) Dosimetric comparison of rapidarc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy. Med Dosim 35:448–454 Yin Y, Ma C, Gao M et al (2010) Dosimetric comparison of rapidarc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy. Med Dosim 35:448–454
15.
Zurück zum Zitat Popescu CC, Olivotto IA, Beckham WA et al (2010) Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional Intensity-Modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 76(1):287–295PubMedCrossRef Popescu CC, Olivotto IA, Beckham WA et al (2010) Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional Intensity-Modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 76(1):287–295PubMedCrossRef
16.
Zurück zum Zitat Scorsetti M, Bignardi M, Alongi F et al (2011) Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: feasibility and clinical preliminary results. Acta Oncol 50(4):528–538PubMedCrossRef Scorsetti M, Bignardi M, Alongi F et al (2011) Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: feasibility and clinical preliminary results. Acta Oncol 50(4):528–538PubMedCrossRef
17.
Zurück zum Zitat Shaffer R, Nichol AM, Vollans E et al (2010) A comparison of volumetric modulated arc therapy and conventional Intensity – modulated radiotherapy for frontal and temporal high-Grade gliomas. Int J Radiat Oncol Biol Phys 76(4):1177–1184PubMedCrossRef Shaffer R, Nichol AM, Vollans E et al (2010) A comparison of volumetric modulated arc therapy and conventional Intensity – modulated radiotherapy for frontal and temporal high-Grade gliomas. Int J Radiat Oncol Biol Phys 76(4):1177–1184PubMedCrossRef
18.
Zurück zum Zitat Wolff D, Stieler F, Hermann B et al (2010) Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO + +. Strahlenther Onkol 186:280–288PubMedCrossRef Wolff D, Stieler F, Hermann B et al (2010) Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO + +. Strahlenther Onkol 186:280–288PubMedCrossRef
19.
Zurück zum Zitat Stieler F, Wolff D, Bauer L et al (2011) Reirradiation of spinal column metastases-comparison of several treatment techniques and dosimetric validation for the use of VMAT. Strahlenther Onkol 187:406–415PubMedCrossRef Stieler F, Wolff D, Bauer L et al (2011) Reirradiation of spinal column metastases-comparison of several treatment techniques and dosimetric validation for the use of VMAT. Strahlenther Onkol 187:406–415PubMedCrossRef
20.
Zurück zum Zitat Dawson LA, Brock KK, Kazanjian S et al (2001) The reproducibility of organ position using active breathing coordinator (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51(5):1410–142PubMedCrossRef Dawson LA, Brock KK, Kazanjian S et al (2001) The reproducibility of organ position using active breathing coordinator (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51(5):1410–142PubMedCrossRef
21.
Zurück zum Zitat Eccles C, Brock K, Bissonnette J et al (2006) Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 64(3):751–759PubMedCrossRef Eccles C, Brock K, Bissonnette J et al (2006) Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 64(3):751–759PubMedCrossRef
22.
Zurück zum Zitat Zhao JD, Xu ZY, Zhu J et al (2008) Application of active breathing coordinator in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit. Radiother Oncol 87:439–444PubMedCrossRef Zhao JD, Xu ZY, Zhu J et al (2008) Application of active breathing coordinator in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit. Radiother Oncol 87:439–444PubMedCrossRef
23.
Zurück zum Zitat Palma DA, Verbakel WFAR, Otto K et al (2010) New developments in arc radiation therapy: a review. Cancer Treat Rev 36:393–399PubMedCrossRef Palma DA, Verbakel WFAR, Otto K et al (2010) New developments in arc radiation therapy: a review. Cancer Treat Rev 36:393–399PubMedCrossRef
24.
Zurück zum Zitat Bortfeld T (2010) The number of beams in IMRT—theoretical investigations and implications for single-arc IMRT. Phys Med Biol 55:83–97PubMedCrossRef Bortfeld T (2010) The number of beams in IMRT—theoretical investigations and implications for single-arc IMRT. Phys Med Biol 55:83–97PubMedCrossRef
25.
Zurück zum Zitat Dawson L, Eccles C, Bissonnette J et al (2005) Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing coordinator. Int J Radiat Oncol Biol Phys 62(4):1247–1252PubMedCrossRef Dawson L, Eccles C, Bissonnette J et al (2005) Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing coordinator. Int J Radiat Oncol Biol Phys 62(4):1247–1252PubMedCrossRef
26.
Zurück zum Zitat Skrzyński W, Zielińska-Dąbrowska S, Wachowicz M et al (2010) Computed tomography as a source of electron density information for radiation treatment planning-CT. Strahlenther Onkol 186:327–333PubMedCrossRef Skrzyński W, Zielińska-Dąbrowska S, Wachowicz M et al (2010) Computed tomography as a source of electron density information for radiation treatment planning-CT. Strahlenther Onkol 186:327–333PubMedCrossRef
27.
Zurück zum Zitat Zurl B, Stranzl H, Winkler P et al (2010) Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH). Strahlenther Onkol 186:157–162PubMedCrossRef Zurl B, Stranzl H, Winkler P et al (2010) Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH). Strahlenther Onkol 186:157–162PubMedCrossRef
28.
Zurück zum Zitat Guckenberger M, Kavanagh A, Webb S et al (2011) A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept – a compromise between small safety margins and long duty cycles. Radiother Oncol 98:317–322PubMedCrossRef Guckenberger M, Kavanagh A, Webb S et al (2011) A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept – a compromise between small safety margins and long duty cycles. Radiother Oncol 98:317–322PubMedCrossRef
29.
Zurück zum Zitat Guckenberger M, Richter A, Wilbert J et al (2010) Adaptive radiotherapy for locally advanced non-small cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. Int J Radiat Oncol Biol Phys, doi:10.1016/j.ijrobp.2011.01.067 Guckenberger M, Richter A, Wilbert J et al (2010) Adaptive radiotherapy for locally advanced non-small cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. Int J Radiat Oncol Biol Phys, doi:10.1016/j.ijrobp.2011.01.067
30.
Zurück zum Zitat Guckenerger M, Wilbert J, Richter A et al (2011) Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 79:901–908CrossRef Guckenerger M, Wilbert J, Richter A et al (2011) Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 79:901–908CrossRef
31.
Zurück zum Zitat Guckenberger M, Sweeney R Wilbert J et al (2008) Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys 71:297–304PubMedCrossRef Guckenberger M, Sweeney R Wilbert J et al (2008) Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys 71:297–304PubMedCrossRef
32.
Zurück zum Zitat Seong J, Park HC, Han KH et al (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma a retrospective study of 158 Patients. Int J Radiat Oncol Biol Phys 55(2):329–336PubMedCrossRef Seong J, Park HC, Han KH et al (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma a retrospective study of 158 Patients. Int J Radiat Oncol Biol Phys 55(2):329–336PubMedCrossRef
33.
Zurück zum Zitat Cilla S, Macchia G, Digesù C et al (2010) 3D-conformal versus intensity-modulated postoperative radiotherapy of vaginal vault: a dosimetric comparison. Med. Dosim 35(2):135–142CrossRef Cilla S, Macchia G, Digesù C et al (2010) 3D-conformal versus intensity-modulated postoperative radiotherapy of vaginal vault: a dosimetric comparison. Med. Dosim 35(2):135–142CrossRef
34.
Zurück zum Zitat Ren ZG, Zhao JD, Gu K et al (2011) Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study. Int J Radiat Oncol Biol Phys 79(2):496–502PubMedCrossRef Ren ZG, Zhao JD, Gu K et al (2011) Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study. Int J Radiat Oncol Biol Phys 79(2):496–502PubMedCrossRef
35.
Zurück zum Zitat Kavanagh BD, Pan CC, Dawson LA et al (2010) Radiation dose–volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 76(3):101–107CrossRef Kavanagh BD, Pan CC, Dawson LA et al (2010) Radiation dose–volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 76(3):101–107CrossRef
36.
Zurück zum Zitat Pan CC, Kavanagh BD, Dawson LA et al (2010) Radiation-associated liver injury. Int J Radiation Oncology Biol Phys 76 (3 Suppl):S94–S100CrossRef Pan CC, Kavanagh BD, Dawson LA et al (2010) Radiation-associated liver injury. Int J Radiation Oncology Biol Phys 76 (3 Suppl):S94–S100CrossRef
37.
Zurück zum Zitat Stromberg JS, Sharpe MB, Kim LH et al (2000) Active breathing coordinator (ABC) for Hodgkin’s disease reduction in normal tissue irradiation with deep inspiration and implications for treatment. Int J Radiat Oncol Biol Phys 48(3):797–806PubMedCrossRef Stromberg JS, Sharpe MB, Kim LH et al (2000) Active breathing coordinator (ABC) for Hodgkin’s disease reduction in normal tissue irradiation with deep inspiration and implications for treatment. Int J Radiat Oncol Biol Phys 48(3):797–806PubMedCrossRef
38.
Zurück zum Zitat Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT. Strahlenther Onkol 187:284–291PubMedCrossRef Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT. Strahlenther Onkol 187:284–291PubMedCrossRef
39.
Zurück zum Zitat Boda-Heggemann J, Fleckenstein J, Lohr F et al (2011) Multiple breath-hold CBCT for online image guided radiotherapy of lung tumors: simulation with a dynamic phantom and first patient data. Radiother Oncol 98:309–316PubMedCrossRef Boda-Heggemann J, Fleckenstein J, Lohr F et al (2011) Multiple breath-hold CBCT for online image guided radiotherapy of lung tumors: simulation with a dynamic phantom and first patient data. Radiother Oncol 98:309–316PubMedCrossRef
40.
Zurück zum Zitat Graf R, Boehmer D, Budach V et al (2010) Residual translational and rotational errors after kv x-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol 186:544–550PubMedCrossRef Graf R, Boehmer D, Budach V et al (2010) Residual translational and rotational errors after kv x-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol 186:544–550PubMedCrossRef
41.
Zurück zum Zitat Guckenberger M, Ok S, Polat B et al (2010) Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 186:535–543PubMedCrossRef Guckenberger M, Ok S, Polat B et al (2010) Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 186:535–543PubMedCrossRef
42.
Zurück zum Zitat Boda-H Guckenberger M, Goebel J, Wilbert J et al (2009) Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 75:828–835CrossRef Boda-H Guckenberger M, Goebel J, Wilbert J et al (2009) Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 75:828–835CrossRef
43.
Zurück zum Zitat Yue J, Sun X, Cai J et al (2010) Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor. Int J Radiat Oncol Biol Phys 82:834–841CrossRef Yue J, Sun X, Cai J et al (2010) Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor. Int J Radiat Oncol Biol Phys 82:834–841CrossRef
44.
Zurück zum Zitat Boda-Heggemann J, Walter C, Mai S et al (2006) Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound. Strahlenther Onkol 182:216–221PubMedCrossRef Boda-Heggemann J, Walter C, Mai S et al (2006) Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound. Strahlenther Onkol 182:216–221PubMedCrossRef
45.
Zurück zum Zitat Mack A, Mack G, Weltz D et al (2003) Quality assurance in stereotactic space. Determination of the accuracy of aim and dose in single dose radiosurgery. Strahlenther Onkol 179:760–766PubMedCrossRef Mack A, Mack G, Weltz D et al (2003) Quality assurance in stereotactic space. Determination of the accuracy of aim and dose in single dose radiosurgery. Strahlenther Onkol 179:760–766PubMedCrossRef
Metadaten
Titel
RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma
verfasst von
G.Z. Gong
Y. Yin
L.G. Xing
Y.J. Guo
T. Liu
J. Chen
J. Lu
C. Ma
T. Sun
T. Bai
G. Zhang
R. Wang
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 3/2012
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-011-0044-5

Weitere Artikel der Ausgabe 3/2012

Strahlentherapie und Onkologie 3/2012 Zur Ausgabe

Mitteilungen der Fachgesellschaften

Mitteilungen

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.